Recent advances and limitations of mTOR inhibitors in the treatment of cancer Cancer Cell International, 15 Sep 2022 Abstract The PI3K-Akt-mechanistic (formerly mammalian) target of the rapamycin (mTOR) signaling pathway is important in a…